We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > SPAC

News List

Drug developer BenevolentAI enters SPAC merger deal with Odyssey Pharmaceutical-Technology
December 08, 2021
UK-based clinical-stage artificial intelligence (AI) drug discovery firm BenevolentAI has signed a definitive agreement for a business combination with the special-purpose acquisition company (SPAC) Odyssey Acquisition.
EQRx signs $1.8bn merger deal with CM Life Sciences III pharmaceutical-technology
August 10, 2021
Pharmaceutical company EQRx and a life science-focused special purpose acquisition company (SPAC), CM Life Sciences III, have signed a definitive business combination agreement worth up to $1.8bn.
Humacyte agrees SPAC merger to go public with bioengineered tissue tech pharmaceutical-technology
February 23, 2021
Human tissue bioengineering biotech Humacyte has entered into a business combination agreement with special purpose acquisition company (SPAC) Alpha Healthcare Acquisition Corp (AHAC).